These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8288891)
1. Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice. Manghi MA; Pasetti MF; Brero ML; Deluchi S; di Paola G; Mathet V; Eriksson PV J Immunol Methods; 1994 Jan; 168(1):17-24. PubMed ID: 8288891 [TBL] [Abstract][Full Text] [Related]
2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
3. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1. Winsnes R; Sesardic D; Daas A; Behr-Gross ME Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay. Gupta RK; Siber GR Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454 [TBL] [Abstract][Full Text] [Related]
5. ELISA for titration of antibodies to tetanus toxoid in sera of immunized guinea pigs as an alternative to the toxin neutralization test in mice. Gupta RK J Immunol Methods; 1995 Feb; 179(2):277-9. PubMed ID: 7876575 [No Abstract] [Full Text] [Related]
6. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation. Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263 [TBL] [Abstract][Full Text] [Related]
7. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies]. Burkin MA; Sviridov VV; Perelygina OV Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723 [TBL] [Abstract][Full Text] [Related]
8. Development of an alternative method for testing the immunogenicity of diphtheria vaccines. Manghi MA; Pasetti MF; Brero ML; Deluchi S; di Paola G; Mathet V; Eriksson PV Vaccine; 1995 Apr; 13(6):597-601. PubMed ID: 7483781 [TBL] [Abstract][Full Text] [Related]
9. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975 [No Abstract] [Full Text] [Related]
10. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet. Rosskopf U; Noeske K; Werner E ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992 [TBL] [Abstract][Full Text] [Related]
11. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid. Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173 [TBL] [Abstract][Full Text] [Related]
12. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460 [TBL] [Abstract][Full Text] [Related]
13. An ELISA system for tetanus toxoid potency tests: An alternative to lethal challenge. Iwaki M; Kenri T; Senoh M Biologicals; 2023 May; 82():101681. PubMed ID: 37130447 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and validation of a commercial ELISA versus the Kitamura N; Endo A; Le LT; Nguyen TB; Do HT; Toizumi M; Yoshida LM; Mori Y; Rose S; Efstratiou A; Fry NK; Litt D J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37338005 [No Abstract] [Full Text] [Related]
15. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use. Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120 [No Abstract] [Full Text] [Related]
16. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines. van der Gun J; Akkermans A; Hendriksen C; van de Donk H Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949 [TBL] [Abstract][Full Text] [Related]
17. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use. Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802 [TBL] [Abstract][Full Text] [Related]
18. Quantitative estimation of diphtheria and tetanus toxoids. 5. Comparative assays in mice and in guinea-pigs of two diphtheria toxoid preparations. Lyng J; Heron I Biologicals; 1991 Oct; 19(4):327-34. PubMed ID: 1797044 [TBL] [Abstract][Full Text] [Related]
19. Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey. Coplu N; Esen B; Gozalan A; Miyamura K; Yoshida I; Kurtoglu D; Dogan NO; Afacan G; Unal A; Ishida S; Takahashi M Jpn J Infect Dis; 2004 Jun; 57(3):97-102. PubMed ID: 15218217 [TBL] [Abstract][Full Text] [Related]
20. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets. Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]